Automated analysis of stool biomarkers with Alegria

Publication
Nov. 29, 2024

Alegria fecal calprotectin reduces TAT helping in the diagnosis of inflammatory bowel diseases with robust results.

The importance of testing anti-dsDNA, anti-nucleosome and anti-C1q antibodies in patients with systemic lupus erythematosus

Publication
Nov. 29, 2024

The flexibility of Alegria monotest solution helps the correct stratification of the SLE patient population.

Anti-MCV – Fill the gap in rheumatoid arthritis diagnosis

Publication
Nov. 29, 2024

This comprehensive meta-analysis highlights the benefit of testing anti-MCV additionally to anti-CCP and RF in the context of early diagnosis of Rheumatoid Arthritis.

Multiple Myeloma: « 20 » and « 100 » Ratios Cut-off applicable to Sebia FLC assays

Publication
Oct. 14, 2022

The « 20 » and « 100 » Ratios Cut-off can be used in routine with Sebia FLC assays for high-risk smoldering multiple myeloma stratification and for assessing progression to active multiple myeloma or amyloidosis.

Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies – MDPI – 2019

Publication
Jan. 12, 2022

This special Issue related to newborn screening for Sickle Cell disease and other hemoglobinopathies tried to cover the most widely faced challenges in the field of newborn screening for SCD.

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Publication
Aug. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

Further evaluation of the world health organization international reference reagent for Haemoglobin A2 measurement

Publication
May. 10, 2021

This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.

Precision of CAPILLARYS 2 for the Detection of Hemoglobin Variants Based on Their Migration Positions

Publication
May. 10, 2021

In this report, we evaluated the use of the capillary electrophoresis (CE) migration position in the CAPILLARYS 2 CE instrument.